Israeli actor Gal Gadot has been awarded Israel’s Genesis Prize in recognition of her strong support for the country at a ...
Pfizer Inc. ( PFE) Discusses Clinical Development Strategy for 4404 Bispecific Antibody in Oncology November 10, 2025 8:30 AM EST ...
Pfizer Inc. acquires Metsera, Inc., beating Novo Nordisk, for up to $86.25/share. Click for my analysis of the deal and what ...
BridgeBio said Pfizer’s filing of a complaint with the NAD “is an attempt to bypass the FDA, the federal agency responsible for overseeing prescription drug advertising, and to challenge promotional ...
Zacks Investment Research on MSN
Pfizer Wins Obesity War Against NVO, to Buy Metsera for Around $10B
The heated bidding war between Pfizer PFE and Danish rival, Novo Nordisk NVO, related to the proposed acquisition of obesity ...
At Celosphere 2025, six enterprise leaders from Pfizer, Deutsche Telekom, DHL, Standard Bank, Metro Bank, and NN Bank ...
Pfizer has signed a deal to purchase Metsera Inc., an obesity drugmaker in the development stage, after winning a bidding war ...
El gigante farmacéutico estadounidense Pfizer firmó un acuerdo para adquirir Metsera Inc., la empresa desarrolladora de ...
The new proposal for the coveted obesity drug developer is more than double the size of Pfizer’s original bid and ends a ...
The obesity drug developer has declared a new proposal from Novo “superior” to Pfizer’s original bid as well as an updated ...
Novo’s bid uses an unusual structure allowing Metsera investors to get most of the money upfront when the deal is signed.
Danish pharmaceutical giant Novo Nordisk, maker of weight-loss drugs Ozempic and Wegovy, announced Thursday an unsolicited bid to acquire obesity treatment maker Metsera, topping an offer from US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback